Skip to main content

Animations

MJFF Publications

1901 - 1910 of 6467 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2026
  • 2022
  • 2021
  • 2021
  • 2023
  • 2021
  • Summary Details
    OPEN
    Title: Undetected ophthalmological disorders in Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-022-11014-0
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661
    Citation Count: 164
  • Summary Details
    OPEN
    Title: Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-022-01031-7
    Citation Count: 71
  • Summary Details
    OPEN
    Title: The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.892493
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Replicability of multivariate brain-behaviour associations depends on clinical profile
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-026-10364-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
    Journal Name: Advances in Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s12325-022-02072-x
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab371
    Citation Count: 80
  • Summary Details
    OPEN
    Title: Proposed research criteria for prodromal behavioural variant frontotemporal dementia
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab365
    Citation Count: 102
  • Summary Details
    OPEN
    Title: The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2023.100261
    Citation Count: 52
  • Summary Details
    OPEN
    Title: echolocatoR : an automated end-to-end statistical and functional genomic fine-mapping pipeline
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.